Queensland COVID-19 research

This page of Queensland’s research related to the COVID-19 pandemic is compiled from information provided by Queensland universities and research institutes.

1. SearchSearch by title, organisation, research details
2. Parent organisation (any) Australian Centre For Health Services Innovation (AusHSI) Bond University CQUniversity Griffith University James Cook University Mater Research QIMR Berghofer Medical Research Institute Queensland Health Queensland University of Technology The University of Queensland The University of Queensland, and The Prince Charles Hospital University of Southern Queensland University of Sunshine Coast University of the Sunshine Coast Wesley Medical Research
3. Sector or topic (any) Advanced manufacturing Antivirals Arts Bioeconomy Business and economics Clinical trials Community perceptions Creative industries Data science Diagnostics Drug development Drug discovery Education Emergency management Epidemiology Evidence based guidelines Exercise Hazard management Humanities Immunology Infection management Intervention evaluation Law Mental health and wellbeing Meta-analysis Modelling Neurological impairment Personal Protective Equipment (PPE) Prevention Public health Social media Social sciences Sun exposure Systematic review Tourism Treatment Urban design and town planning Vaccine Zoonotics
4. • Reset

• Ancient Australian plant may help in production of COVID-19 vaccine April 2020

  QUT researchers are embedded in an international team of scientists developing technologies to produce large amounts of low-cost vaccines. Professor Peter Waterhouse has developed a roadmap for biotechnologists who are turning to the new technique of producing antibodies, vaccines and therapeutics, in plants - biofactories. Plants can be grown in large amounts using simple agricultural technologies, that are within reach of developing countries that may lack sophisticated protein production methods. In this “molecular farming” discipline, biotechnologists can alter the DNA instructions in a plant to make it produce the antibody or vaccine in the cells and sap of its leaves and the plant does the rest. Professor Waterhouse said several international biotech companies have already been given fast-tracked access to the entire chromosome-level genome sequence of the Australian-native plant Nicotiana benthamiana. QUT have made this previously unpublished information available to any team working on fighting the COVID-19 pandemic to allow them to ‘tweak’ the genome to produce better quality vaccines and therapeutics. The plant is being used all over the world as the vaccine plant biofactory of choice and the genome sequencing has been led by Professor Waterhouse in partnership with the European Horizon 2020 Newcotiana consortium.

  #Bioeconomy

  Centre

  Centre for Agriculture and the Bioeconomy
  Queensland University of Technology

  Contact details

  Prof Peter Waterhouse
  peter.waterhouse@qut.edu.au
  +61 7 3138 7793

  Collaborations

  European Horizon 2020 Newcotiana consortium